A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

Clinical trial NCT05543629 · TERMINATED

Trial details

NCT number: NCT05543629
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Non-small Cell Lung Cancer

Start date: 2022-10-04
Primary completion: 2024-09-12
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.